• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BDM
Click for more information
0.00% 14.0¢

BURGUNDY DIAMOND MINES LIMITED - News & Media

Market Cap $198.9M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Burgundy Diamond Mines Limited is an Australia-based premier independent global scale... Burgundy Diamond Mines Limited is an Australia-based premier independent global scale diamond company. The principal activities of the Company include operation of the 100% owned Ekati diamond mine located in Canada’s Northwest Territories, sale of rough diamonds through auctions held in Antwerp Belgium and sale of polished diamonds manufactured in Company’s cutting and polishing facility in Perth Australia. It is focused on the mining, production, cutting, polishing and sale of diamonds. Its segments include Rough Diamond and Polished Diamond. The Rough Diamond segment encompasses mining, sales, and marketing of rough diamonds. The Polished Diamond segment encompasses manufacturing, sales, and marketing of polished diamonds. Its Ekati diamond mine is located in the Lac de Gras region of the Northwest Territories of Canada, approximately 300 kilometers northeast of Yellowknife. The Ekati Mine property consists of 122 mining leases totaling about 113,485 hectares.More

Articles & Videos

Burgundy Diamond Mines (ASX:BDM) to complete "transformational" acquisition of Ekati diamond mine, Canada

Burgundy Diamond Mines (ASX:BDM) has entered a binding share purchase agreement (SPA) with Artic Canadian to acquire the "world-class" Ekati diamond mine in Canada.

14 Mar 2023 14:00 (AEDT)



(20min delay)
Last
14.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $198.9M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 7142 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 794 1
View Market Depth
Last trade - 09.05am 02/10/2024 (20 minute delay) ?
BDM (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Firebird achieves preliminary approvals for its Jinshi plant design Firebird Metals Ltd has reached a significant stage in development of its battery-grade manganese sulphate plant in China
Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.